Pharmanovia A/S: Financial statements 2026
CVR: 32287824
Source: annual report 2026, Danish Business Authority
01/04/2025 – 31/03/2026
Pharmanovia A/S (CVR 32287824) has filed annual accounts for 2026. In 2026, the company reported a gross profit of EUR 11,734,813 and a net result of EUR 7,730,657 compared with DKK 3,839,334 the year before. That is an increase of 94.8% compared with the year before. Equity in the 2026 report amounted to EUR 15,820,601. The solvency ratio was 49%. The company had 9 employees in the financial year.
- Gross Profit
- EUR 11,734,813
- Profit/Loss
- EUR 7,730,657
- Equity
- EUR 15,820,601
- Total Assets
- EUR 32,312,149
- Employees
- 9
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2026 | - | 11.7M EUR | 7.7M EUR | 15.8M EUR | 9 |
| 2025 | - | 6M | 3.8M | 8.1M | 12 |
| 2024 | - | 4.7M EUR | 2.2M EUR | 4.9M EUR | 12 |
| 2023 | - | 44M | 26.1M | 19.6M | 15 |
| 2022 | - | 3.4M | -21.6M | -6.5M | 18 |
Official annual report
Find more companies like Pharmanovia A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2026
As of June 9, 2026, Neeshe Bhikhubhai Williams has left the board of directors of Pharmanovia A/S.
As of June 9, 2026, Christoph Michael Habereder is registered as director of Pharmanovia A/S.
As of June 9, 2026, Neeshe Bhikhubhai Williams has stepped down as director of Pharmanovia A/S.
As of March 24, 2026, Mohammad Muqtadir Samy has joined the board of directors of Pharmanovia A/S.
As of March 24, 2026, Amit Vijaykumar Patel has left the board of directors of Pharmanovia A/S.
As of March 23, 2026, Mohammad Muqtadir Samy has left the board of directors of Pharmanovia A/S.
As of February 17, 2026, Twan Johannes Anna Nouwen has joined the board of directors of Pharmanovia A/S.
As of February 17, 2026, Mohammad Muqtadir Samy has joined the board of directors of Pharmanovia A/S.
As of February 17, 2026, Christoph Michael Habereder has joined the board of directors of Pharmanovia A/S.
As of February 17, 2026, Santsagar Patel has left the board of directors of Pharmanovia A/S.
About Pharmanovia A/S
Pharmanovia A/S is a Danish company of the type Aktieselskab based in København S, founded in 2009. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Atnahs Pharma Nordics A/S and PHARMANOVIA A/S. The management consists of Christoph Michael Habereder. The board consists of Mohammad Muqtadir Samy (chair), Christoph Michael Habereder and Twan Johannes Anna Nouwen. The company is owned by Atnahs Pharma UK Limited. The company has 3 employees (2026). In 2026, the company reported a gross profit of EUR 11,734,813 and a net result of EUR 7,730,657 compared with DKK 3,839,334 the year before. Equity in the 2026 report amounted to EUR 15,820,601.